U.S. Tobacco Stock News

NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

How Conference Updates and Easing Geopolitics Could Shape Gibraltar Industries' (ROCK) Risk Perception

Gibraltar Industries recently presented at the 38th Annual Roth Conference at The Ritz-Carlton Laguna Niguel in Dana Point, California, with CEO Bill Bosway and CFO Joe Lovechio outlining the company’s latest business updates to investors. A separate easing of geopolitical tensions in the Middle East lifted sentiment toward industrial and construction-related names, placing Gibraltar within a broader group of companies perceived as benefiting from reduced global risk. With improved sentiment...
NYSE:MPC
NYSE:MPCOil and Gas

Marathon Petroleum Governance Vote And What It Could Mean For Valuation

Marathon Petroleum (NYSE:MPC) has scheduled a shareholder vote on a proposed amendment to its Certificate of Incorporation at the 2026 Annual Meeting. The proposal focuses on corporate governance terms that could influence shareholder rights and future decision making at the company. Investors will have the opportunity to review and vote on the amendment as part of the formal meeting agenda. Marathon Petroleum operates as a large US refiner and fuel marketer, so changes to its governance...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte Taps Kevin Haas To Guide AI Push And Undervalued Shares

Veracyte, NasdaqGM:VCYT, has appointed Kevin Haas, Ph.D., as Chief Development and Technology Officer in a newly created executive role. Dr. Haas will oversee assay development, software, AI, and next generation informatics across Veracyte's product pipeline. The move reflects Veracyte's focus on whole genome MRD and multi omics applications across its global portfolio. Veracyte's share price stands at $32.94, with a return of 60.1% over the past 3 years and a 2.2% decline over the past...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

How Investors Are Reacting To CVB Financial (CVBF) Beating Estimates While Affirming Its 2026 Dividend

CVB Financial Corp. recently approved a US$0.20 per share cash dividend for the first quarter of 2026, payable on or about April 15, 2026, to shareholders of record as of April 1, 2026. This dividend affirmation reinforces the bank’s emphasis on returning cash to shareholders even as its latest quarterly results exceeded analyst expectations on revenue, net interest income, and earnings per share. With this fresh dividend declaration as a backdrop, we’ll explore how CVB Financial’s latest...
NYSE:WRBY
NYSE:WRBYSpecialty Retail

Warby Parker (WRBY) Valuation Check After Recent Share Price Weakness And AI Eyewear Ambitions

Warby Parker stock at a glance Warby Parker (WRBY) trades at US$23.06 after a 4.6% one day decline, with the share price also lower over the past week, month and past 3 months, while the 1 year total return remains positive. See our latest analysis for Warby Parker. The recent 4.6% one day share price decline to US$23.06 comes after weaker short term share price returns over the past three months. This is occurring even as the 1 year total shareholder return of 14.4% and 3 year total...
NYSE:JAN
NYSE:JANHealth Care REITs

Janus Living Adds $600m Unsecured Credit To Support Future Growth Choices

Janus Living (NYSE:JAN) has arranged $600 million in new unsecured credit facilities. The package includes a $500 million unsecured revolving credit facility and a $100 million unsecured delayed draw term loan facility. The new funding is intended to increase liquidity and support future expansion plans. For investors watching NYSE:JAN, the new credit facilities arrive with the stock at $23.75 and a year-to-date return of 0.6%. The move reshapes Janus Living's funding options as a REIT and...
NasdaqCM:PESI
NasdaqCM:PESICommercial Services

Perma Fix Environmental Services (PESI) Loss Narrows To US$0.10 EPS Challenging Bearish Narratives

Perma-Fix Environmental Services (PESI) FY 2025 earnings snapshot Perma-Fix Environmental Services (PESI) reported third quarter FY 2025 revenue of US$17.5 million with a basic EPS loss of US$0.10, while trailing twelve month EPS stood at a loss of US$0.64 on revenue of US$60.7 million. This highlights that the business remains in loss making territory. Over recent quarters, revenue has ranged from US$13.9 million to US$17.5 million, while quarterly EPS losses have moved between US$0.09 and...
NasdaqGS:AVPT
NasdaqGS:AVPTSoftware

Is AvePoint (AVPT) Offering A Long Term Opportunity After Recent Share Price Weakness

If you are wondering whether AvePoint's current share price lines up with its underlying worth, this breakdown will help you make sense of what the market is implying. The stock recently closed at US$9.61, with returns of 8.4% decline over 7 days, 8.5% decline over 30 days, 27.3% decline year to date, 36.9% decline over 1 year, 146.4% gain over 3 years, and 13.3% decline over 5 years, so the recent share price path has been mixed across different time frames. Recent news coverage has focused...
NYSE:WBS
NYSE:WBSBanks

Is Webster Financial (WBS) Still Attractive After Strong Multi Year Share Price Gains

Investors may be wondering if Webster Financial at around US$68.67 is offering reasonable value today, or if the recent run has already priced in the upside. The stock is up 34.0% over the past year and 93.1% over three years, with a 7.6% gain year to date, even though it has seen a 6.0% decline over the last month and a small 0.3% move over the past week. Recent attention on banks listed on the New York Stock Exchange has put valuation and balance sheet quality back in focus, and Webster...
NYSEAM:BATL
NYSEAM:BATLOil and Gas

Battalion Oil (BATL) TTM Loss Of US$55.2m Tests Bullish Loss‑Narrowing Narratives

Recent Results Set the Stage for Battalion Oil’s Next Chapter Battalion Oil (BATL) just posted its latest FY 2025 numbers with Q3 revenue of US$43.5 million and a basic EPS loss of US$0.91, alongside trailing twelve month revenue of US$183.4 million and a basic EPS loss of US$3.35. Over the past few quarters, total revenue has moved between US$42.8 million and US$49.7 million while quarterly basic EPS has ranged from a loss of US$1.88 to a profit of US$0.34. This gives investors a mixed read...
NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Concentrix (CNXC) Margin Collapse With Q4 EPS Loss Tests Bullish Turnaround Narratives

Concentrix (CNXC) has just wrapped up its Q1 2026 reporting cycle with recent quarterly numbers showing Q4 2025 revenue of US$2.6 billion and a basic EPS loss of US$23.74, alongside net income excluding extra items of a US$1.47 billion loss. Over the past six reported quarters, revenue has ranged from US$2.4 billion to US$2.6 billion while basic EPS has swung from a profit of US$1.73 in Q4 2024 to a loss of US$23.74 in Q4 2025. This sets up a results season where margins and the path back to...
NasdaqGS:CDNL
NasdaqGS:CDNLConstruction

Cardinal Infrastructure Group (CDNL) Revenue Growth Challenges Margin Concerns In FY 2025 Results

Cardinal Infrastructure Group (CDNL) just closed FY 2025 with fourth quarter revenue of US$145.8 million and net income of US$2.9 million, translating to EPS of about US$0.20. Over the past year, the company has seen trailing 12 month revenue move from US$315.2 million to US$456.0 million, while trailing net margin sits at 5% compared with 6.8% a year earlier, setting a clear context for how profitability is tracking against growth. For investors, this mix of higher top line and softer...
NasdaqGM:STRO
NasdaqGM:STROBiotechs

Sutro Biopharma Q3 Loss Of US$56.9 Million Tests Profitability Narratives For STRO Investors

Latest FY 2025 Results: Revenue Pressure and Deep Losses at Sutro Biopharma (STRO) Sutro Biopharma (STRO) has put out fresh FY 2025 numbers, with Q3 total revenue of US$9.7 million, a basic EPS loss of US$6.70, and net income loss excluding extra items of US$56.9 million setting the tone for the update. The company has seen quarterly revenue move between US$8.5 million and US$63.7 million over the last six reported periods, while basic EPS has ranged from a loss of US$1.36 to a loss of...
NYSE:RS
NYSE:RSMetals and Mining

Is Reliance (RS) Still Sensibly Priced After Recent Pullback And Long Term Gains

Wondering if Reliance at around US$300.22 is offering value or asking you to pay up for quality is exactly the question this breakdown will help you tackle. The stock is up 0.4% over the last 7 days and 1.5% year to date, but a 5.9% pullback over the past month sits against a 4.1% 1 year return, 22.8% over 3 years and 115.4% over 5 years. Recent coverage has focused on Reliance as a long term Metals and Mining name. Investor attention has been drawn to how its multi year share performance...
NasdaqGS:BIOA
NasdaqGS:BIOAPharmaceuticals

BioAge Labs (BIOA) Heavy Quarterly Loss Reinforces Bearish Community Narrative On Profitability

BioAge Labs (BIOA) just posted its FY 2025 third quarter numbers, reporting revenue of US$2.1 million and a basic EPS loss of US$0.56, alongside a net loss of US$20.2 million, keeping the story firmly in loss-making territory. Over recent quarters, revenue has moved from US$0 million in Q4 2024 to US$1.5 million in Q1 2025 and US$2.4 million in Q2 2025. Quarterly basic EPS has remained in loss-per-share territory between US$0.36 and US$0.60, which keeps the focus on the pace at which losses...
NasdaqCM:WILC
NasdaqCM:WILCConsumer Retailing

G. Willi-Food International (NasdaqCM:WILC) One Off Gain Puts 132.9% Earnings Growth In Question

G. Willi-Food International (NasdaqCM:WILC) has just reported another solid stretch of results, with Q2 FY 2025 revenue of ₪160.5 million and basic EPS of ₪2.30, set against trailing twelve month EPS of ₪6.94 on revenue of ₪598.4 million as the company caps off a year where net earnings grew 132.9%. Over the past few reporting periods, revenue has moved from ₪146.7 million in Q2 FY 2024 to ₪160.5 million in Q2 FY 2025, while quarterly EPS has ranged from ₪0.49 to ₪2.30, feeding into a...
NYSE:EXP
NYSE:EXPBasic Materials

How Baupost’s Stake Buildup and New Coverage At Eagle Materials (EXP) Has Changed Its Investment Story

In recent quarters, Baupost steadily increased its stake in Eagle Materials Inc., with fourth-quarter 2025 filings showing a 27% rise in holdings since the prior quarter, while RBC Capital Markets initiated coverage with a Sector Perform rating. This combination of expanding institutional ownership and fresh analyst attention has brought new focus to how Eagle Materials’ mixed heavy and light building materials portfolio is being valued. Next, we’ll examine how Baupost’s larger position...
NYSE:CNM
NYSE:CNMTrade Distributors

Core And Main (CNM) EPS Strength Tests Bullish Long Term Growth Narrative

Core & Main (CNM) has reported third quarter FY 2026 revenue of US$2.1 billion and basic EPS of US$0.72, with trailing twelve month revenue at US$7.8 billion and EPS at US$2.29. The company has seen revenue move from US$1.7 billion in Q4 FY 2025 to US$2.1 billion in Q3 FY 2026, while quarterly EPS has ranged from US$0.34 to US$0.72 over that span. This release is part of a steady earnings run supported by broadly consistent margins. See our full analysis for Core & Main. With the headline...
NasdaqCM:SMTI
NasdaqCM:SMTIMedical Equipment

Sanara MedTech (SMTI) Q3 Profit From Continuing Operations Tests Loss‑Focused Bear Narratives

Sanara MedTech (SMTI) just posted its latest FY 2025 numbers, with Q3 revenue at US$26.3 million and basic EPS of US$0.10 from continuing operations, while trailing twelve month figures show revenue of US$101.9 million and a basic EPS loss of US$0.71. Over recent quarters the company has seen revenue range from US$20.2 million to US$26.3 million and quarterly basic EPS swing between a loss of US$0.41 and a profit of US$0.10, with trailing twelve month earnings from discontinued operations...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

Is It Time To Reassess ArcBest (ARCB) After Recent Share Price Swings?

Wondering whether ArcBest at around US$94.60 is offering value right now or asking too much of future expectations? This article breaks down what the current price could be telling you. The share price has moved 10.1% over the last 7 days, while the 30 day return stands at a 10.0% decline and the 1 year return is 29.7%, with 22.6% year to date. Recent news coverage has focused on ArcBest as a transportation and logistics player in a sector that often reacts quickly to shifts in freight...
NasdaqGS:LENZ
NasdaqGS:LENZPharmaceuticals

LENZ Therapeutics (LENZ) Loss Deepens As VIZZ Launch Tests Bullish Growth Narratives

Financial results set the stage for LENZ Therapeutics (LENZ) LENZ Therapeutics (LENZ) has reported fresh numbers for FY 2025, with third quarter revenue of US$12.5 million and a loss per share of US$0.59, as net income excluding extra items came in at a loss of US$16.7 million. The company’s revenue moved from US$0 in the second quarter of 2024 to US$12.5 million in the third quarter of 2025. Over the same period, basic EPS shifted from a loss of US$0.38 to a loss of US$0.59. This provides a...
NasdaqGS:BZ
NasdaqGS:BZProfessional Services

Has Kanzhun (BZ) Fallen Too Far After Its Recent Share Price Slump

If you are wondering whether Kanzhun's current share price reflects its real value, the recent moves in the stock give you plenty to think about. The stock closed at US$13.26, with returns of an 8.9% decline over the past week, a 24.1% decline over the past month, and a 36.6% decline year to date, adding to a 33.0% decline over the last year and a 28.9% decline over three years. These moves have put valuation firmly in focus for many investors who want to understand whether the share price...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

A Look At LivaNova (LIVN) Valuation After Recent Share Price Weakness

LivaNova Stock: Event Trigger and Initial Takeaways LivaNova (LIVN) has drawn investor attention after recent share performance data showed a 1 day decline of about 1.3% and a roughly 8.8% drop over the past month. See our latest analysis for LivaNova. While the 30 day share price return of about 8.8% and the recent 1 day move have been weak, the 1 year total shareholder return of 56.31% and 3 year total shareholder return of 48.50% suggest earlier momentum has eased rather than reversed. If...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

PTC Refocuses Portfolio As Kepware Sale Adds Cash And Raises Questions

PTC has completed the sale of its Kepware and ThingWorx businesses to TPG, reshaping its portfolio around remaining operations. The transaction delivers substantial cash proceeds to PTC and is accompanied by updated financial guidance reflecting the new structure. The divestiture marks a change in focus for PTC, which trades on NasdaqGS:PTC, and follows a period of weaker recent share price performance. Shares of PTC, ticker NasdaqGS:PTC, last closed at $142.96, with returns of 16.0% over 3...